As the pandemic continues, the global biomedical research community is working urgently to identify coronavirus risk factors and potential therapeutic targets.
"We can not assume that groups who are at low risk of life threatening disease and death during acute infections are also at low risk of ongoing COVID", the researchers said.
The two studies provide further evidence that blood type or blood group may play a major role in a person's susceptibility to infection and their chance of having a severe bout of the disease. Researchers from Canada from February to April 2020 observed patients with COVID-19 and came to the conclusion that patients with the second ("A") and fourth ("AB") blood groups are more at risk of facing such a problem as organ failure. time of treatment for coronavirus infection.
Health officials have estimated that 60,000 people could be suffering with long-term after effects of COVID-19.
The growth rate, which estimates how quickly the number of infections is changing day by day, is between plus four per cent and plus seven per cent for the United Kingdom as a whole. Since blood group distributions vary among ethnic subgroups, the researchers also controlled for ethnicity and maintained that fewer people with blood type O tested positive for the virus. "And if you're blood group O, you're not free to go to the pubs and bars".
This lends credence to the fact that people with blood type A, B and AB, may be more at risk of getting infected than those with blood type O. They found that patients with blood groups A or AB were more likely to require mechanical ventilation, suggesting that they had greater rates of lung injury from COVID-19.
But the ONS said there are now also more signs of growth in the age groups covering 25 to 69-year-olds.
The median length of staying in intensive care units was 13.5 days for patients with A or AB blood types, while it was only nine days for patients with O or B blood types, the study found.
The report, which has since received added boost from Reuters and others, is the latest effort by medical experts who are commendably trying to bring both awareness of and knowledge to COVID-19 patients who haven't experienced a cut-and-dry experience of being well, then sick, then well again.
The results of the Danish study could have an impact on who will be the first in the country to receive a future vaccine, writes broadcaster DR.